glp 1 semaglutida GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations PDB-101: Diabetes Mellitus: Diabetes Mellitus:
Description
Monitoring requirements: weight, blood pressure, lipids, HbA1c if relevant
As of April 2026, tirzepatide remains on the shortage list
Furthermore, GLP-1 RAs seem to have similar safety profile in the IBD population to the one observed in the general population, based on real-world observations
Their value lies in situations where metabolic dysfunction actively contributes to age-related decline
Its how do I come off it well. The answer is built while youre still on it
Retatrutide falls squarely within this expected range, and at the favorable end of it
